AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

NASDAQ:CURNeuralstem Competitors & Alternatives

$0.88
-0.01 (-1.13 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.83
Now: $0.88
$0.90
50-Day Range
$0.69
MA: $0.82
$0.96
52-Week Range
$1.10
Now: $0.88
$13.78
Volume1.55 million shs
Average Volume1.98 million shs
Market Capitalization$1.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81

Competitors

Neuralstem (NASDAQ:CUR) Competitors and Alternatives

The following companies in the "biological products, except diagnostic" industry are considered alternatives and competitors to Neuralstem.

Competitor NameBeat the Market RankCurrent PricePrice ChangeMarket CapRevenueP/E RatioIndicator(s)
Amgen logo
AMGN
Amgen
2.3$225.67-2.1%$129.73 billion$23.36 billion17.69Analyst Report
Analyst Revision
Gilead Sciences logo
GILD
Gilead Sciences
2.2$76.75-1.0%$96.62 billion$22.45 billion19.73Analyst Report
Analyst Revision
Biogen logo
BIIB
Biogen
1.7$306.72-2.3%$48.90 billion$14.38 billion9.47Heavy News Reporting
Seattle Genetics logo
SGEN
Seattle Genetics
1.3$148.39-1.4%$26.04 billion$916.71 million-78.93
MRNA
Moderna
1.6$58.19-4.1%$22.23 billion$60.21 million-38.79Analyst Report
BNTX
BioNTech
0.9$49.18-1.7%$11.58 billion$121.63 million-51.77Analyst Downgrade
Neurocrine Biosciences logo
NBIX
Neurocrine Biosciences
1.8$115.86-3.7%$10.83 billion$788.10 million62.97Analyst Downgrade
Qiagen logo
QGEN
Qiagen
1.0$44.36-0.6%$10.04 billion$1.53 billion-277.25
BIO-TECHNE logo
TECH
BIO-TECHNE
2.0$252.55-2.7%$9.92 billion$714.01 million53.39Analyst Upgrade
Insider Selling
argenx logo
ARGX
argenx
1.2$225.95-2.3%$9.86 billion$78.17 million-47.77
Repligen logo
RGEN
Repligen
1.4$120.26-1.3%$6.65 billion$270.24 million267.25
ALLO
Allogene Therapeutics
1.3$42.63-0.9%$5.39 billionN/A-21.42Insider Buying
Analyst Revision
ADPT
Adaptive Biotechnologies
1.5$39.20-1.2%$5.03 billion$85.07 million-22.27Analyst Report
Insider Selling
Acceleron Pharma logo
XLRN
Acceleron Pharma
1.5$91.54-0.6%$5.03 billion$73.99 million-35.34Analyst Report
Spark Therapeutics logo
ONCE
Spark Therapeutics
1.1$113.57-0.0%$4.37 billion$64.72 million-53.82Heavy News Reporting
China Biologic Products logo
CBPO
China Biologic Products
0.7$109.00-0.6%$4.33 billion$503.70 million27.59
Crispr Therapeutics logo
CRSP
Crispr Therapeutics
1.2$62.26-2.3%$3.96 billion$289.59 million83.01Insider Selling
Iovance Biotherapeutics logo
IOVA
Iovance Biotherapeutics
1.7$31.41-1.8%$3.95 billionN/A-17.16Analyst Downgrade
Analyst Revision
bluebird bio logo
BLUE
bluebird bio
1.5$70.98-5.7%$3.72 billion$44.67 million-4.74Analyst Revision
Momenta Pharmaceuticals logo
MNTA
Momenta Pharmaceuticals
1.2$32.21-6.6%$3.49 billion$23.87 million-11.50Analyst Downgrade
Halozyme Therapeutics logo
HALO
Halozyme Therapeutics
2.2$23.26-1.5%$3.14 billion$195.99 million-42.29
Denali Therapeutics logo
DNLI
Denali Therapeutics
1.4$25.93-4.1%$2.93 billion$26.68 million-11.79
Novavax logo
NVAX
Novavax
1.8$46.30-3.5%$2.56 billion$18.66 million-11.18Analyst Downgrade
ALEC
Alector
1.0$29.99-1.1%$2.40 billion$21.22 million-16.57Analyst Report
Fate Therapeutics logo
FATE
Fate Therapeutics
1.5$30.04-2.8%$2.33 billion$10.68 million-19.13
RVMD
Bill.com
1.8$32.85-0.5%$1.98 billionN/A0.00Heavy News Reporting
SWTX
SpringWorks Therapeutics
1.5$37.58-7.0%$1.73 billionN/A-10.59
Adverum Biotechnologies logo
ADVM
Adverum Biotechnologies
1.0$22.67-10.5%$1.65 billion$250,000.00-20.99
Sangamo Therapeutics logo
SGMO
Sangamo Therapeutics
1.6$10.97-2.4%$1.62 billion$102.43 million-13.22Analyst Downgrade
TWST
Twist Bioscience
1.3$36.86-0.6%$1.60 billion$54.38 million-8.34Analyst Downgrade
Insider Selling
Adaptimmune Therapeutics logo
ADAP
Adaptimmune Therapeutics
0.9$11.25-1.2%$1.55 billion$1.12 million-8.59Insider Selling
Mesoblast logo
MESO
Mesoblast
1.2$12.83-0.4%$1.50 billion$16.72 million-20.05Analyst Downgrade
Unusual Options Activity
Editas Medicine logo
EDIT
Editas Medicine
1.3$26.66-1.4%$1.48 billion$20.53 million-9.59
BEAM
Beam Therapeutics
0.6$27.28-3.1%$1.45 billion$20,000.00-1.94
BDTX
I-Mab
1.3$38.67-3.7%$1.44 billionN/A-2.28
Regenxbio logo
RGNX
Regenxbio
1.5$37.34-1.2%$1.37 billion$35.23 million-13.43
Coherus Biosciences logo
CHRS
Coherus Biosciences
1.5$18.74-0.6%$1.33 billion$356.07 million9.56Analyst Downgrade
Proteon Therapeutics logo
PRTO
Proteon Therapeutics
0.8$54.59-6.0%$1.28 billionN/A-47.47
CRTX
Cortexyme
2.0$41.47-6.3%$1.24 billionN/A-20.63Analyst Report
Analyst Revision
NanoString Technologies logo
NSTG
NanoString Technologies
1.1$30.52-3.3%$1.17 billion$125.57 million-18.61
Compugen logo
CGEN
Compugen
1.6$13.61-8.2%$1.17 billion$17.80 million-34.02
PASG
Passage Bio
1.9$25.75-5.2%$1.17 billionN/A0.00
TBIO
Translate Bio
1.2$14.87-5.2%$983.91 million$7.80 million-8.75Analyst Downgrade
Insider Selling
ORTX
Orchard Therapeutics
1.5$9.50-1.9%$923.97 million$2.51 million-4.97
Krystal Biotech logo
KRYS
Krystal Biotech
1.4$47.32-2.5%$835.39 millionN/A-38.16Analyst Report
Heavy News Reporting
Sorrento Therapeutics logo
SRNE
Sorrento Therapeutics
2.0$4.12-6.3%$809.40 million$31.43 million-2.37Analyst Downgrade
Avrobio logo
AVRO
Avrobio
1.4$22.84-4.1%$777.28 millionN/A-8.37
BioCryst Pharmaceuticals logo
BCRX
BioCryst Pharmaceuticals
1.5$4.17-4.6%$769.10 million$48.83 million-4.44Analyst Downgrade
Replimune Group logo
REPL
Replimune Group
1.6$23.51-14.1%$739.88 millionN/A-15.47Earnings Announcement
Analyst Report
Analyst Revision
Heavy News Reporting
Cellectis logo
CLLS
Cellectis
1.3$16.37-4.0%$739.40 million$22.99 million-10.36
This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.